Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Multicenter Double-blind Placebo-controlled Randomized Parallel Group Clinical Trial of Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in Children

NCT02072174 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT02072174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02072174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Multicenter Double-blind Placebo-controlled Randomized Parallel Group Clinical Trial of Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in Children
Lead sponsor
Materia Medica Holding
Phase
Phase 4
Overall status
Completed
Start date
October 8, 2014
Completion date
April 16, 2018
Enrollment
569 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

influenza and acute respiratory viral infections